Molecular recognition of HER-1 in whole-blood samples.

about

Molecular recognition of HER-1 in whole-blood samples.

Item

http://www.wikidata.org/entity/Q54318003

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Molecular recognition of HER-1 in whole-blood samples.

@en

Molecular recognition of HER-1 in whole-blood samples.

@nl

type

Item

label

Molecular recognition of HER-1 in whole-blood samples.

@en

Molecular recognition of HER-1 in whole-blood samples.

@nl

prefLabel

Molecular recognition of HER-1 in whole-blood samples.

@en

Molecular recognition of HER-1 in whole-blood samples.

@nl

P1476

Molecular recognition of HER-1 in whole-blood samples.

@en

P2093

Camelia Stanciu Gavan

http://www.w3.org/2001/XMLSchema#string

Iuliana Moldoveanu

http://www.w3.org/2001/XMLSchema#string

Raluca-Ioana Stefan-van Staden

http://www.w3.org/2001/XMLSchema#string

P2860

Role of HER2 gene overexpression in breast carcinoma.

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action

Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?

Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer.

Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique.

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions.

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma.

Electrochemical immunosensor for label free epidermal growth factor receptor (EGFR) detection.

P304

653-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMR.2388

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25277089

http://www.w3.org/2001/XMLSchema#string